Crown (CCK) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
8 Jan, 2026Executive summary
Q4 2024 adjusted EPS was $1.59, up 28% year-over-year; reported EPS was $3.02, including a $2.32 gain from the Eviosys sale.
Net sales for 2024 were $11,801 million, with 2% year-over-year growth driven by 5% higher global beverage can shipments and higher food can volumes, offset by lower Transit Packaging volumes and material costs.
Record adjusted EBITDA for 2024 reached $1.942 billion, up from $1.882 billion in 2023, supported by 5% global beverage can growth.
Free cash flow reached a record $814 million after pension contributions and tax payments; net debt reduced by $878 million, with net leverage at 2.7x.
Net income for 2024 was $424 million, down from $450 million in 2023, due to non-recurring items.
Financial highlights
Segment income for 2024 increased by $99 million to $1,645 million, mainly from global beverage operations.
Adjusted EBITDA margin for 2024 was approximately 16.5%.
Operating cash flow for 2024 was $1,192 million.
Adjusted diluted EPS for 2024 was $6.41, up from $5.86 in 2023.
Income from operations for 2024 was $1,419 million, up from $1,269 million in 2023.
Outlook and guidance
2025 adjusted diluted EPS expected in the range of $6.60–$7.00; Q1 2025 adjusted EPS projected at $1.20–$1.30.
2025 adjusted free cash flow projected at $800 million after $450 million in capital spending.
North American beverage volumes expected to be flat in 2025, Brazil projected for mid-single-digit growth.
European Beverage expected to deliver another record year in 2025; Asia-Pacific income forecasted to be flat to up.
Non-reportable businesses income expected up 10% in 2025.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Q1 net income up to $193M, adjusted EPS up 64%, and guidance raised on strong can demand.CCK
Q1 20256 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025